G88(P) Immunodeficiency in children with down syndrome. (12th March 2018)

• Record Type: Journal Article
• Authors: Huggard, D; Mahon, M; McGrane, F; Lagan, N; Purcell, C; Balfe, J; Roche, E; Molloy, E
• Is Part Of: Archives of disease in childhood. Volume 103(2018)Supplement 1
• Page Start: A36
• Page End: A37
• Publication Date: 2018-03-12
• Subjects: Children -- Diseases -- Periodicals; Infants -- Diseases -- Periodicals; 618.920005
• DOI: 10.1136/archdischild-2018-rcpch.86
• Languages: English
• ISSNs: 0003-9888

Abstract

Abstract : Aims: Down Syndrome (DS) is the most common genetic syndrome associated with abnormal immune function and immune defects. There is an increased susceptibility to both bacterial and viral infections. We aimed to examine the degree of immunodeficiencies in children with DS. Methods: Children who attended the specialist multidisciplinary DS clinic in Tallaght were included, and medical details collected especially in relation to infections, recurrent respiratory tract infections (RTIs), hospital admissions and vaccinations. Results of Full blood counts, T and B cell subsets and immunoglobulins were analysed and compared to age specific reference ranges. Results: Twenty-eight children (age range 1–12 years) were included and 16/28 (57%) had recurrent RTIs. Hospitalisation at least once was necessary in 15/28 (54%) patients, and 6/28 (21%) required multiple admissions. All but one patient's routine immunisations were up to date (96%). Although 22 children had a normal white cell count (WCC), Neutrophil and lymphocyte levels, T and B cell subsets (n=13) revealed decreased CD3+, Helper T, Cytotoxic T and CD19 +B cells, with the latter being significantly reduced. IgA and IgG levels were normal or high in all cases, and levels were either normal or low for IgM. Conclusion: We found that children with DS were at increased risk of infections, especially recurrent RTIs, with a significant hospitalisation rate. Vaccination compliance was very high, however the CD19 +B cells were found to be low, which may point to a poor memory B cell response. Further research to evaluate individualised vaccination and prophylactic programmes would be valuable in this cohort.